Alcidion Group Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision that combines artificial intelligence, clinical decision support, and mobile alerts in clinical dashboard; Patientrack, a patient safety and communication system; and Smartpage, a messaging and task management platform, which enables hospital staff to communicate and collaborate. It also provides project management, data and analytics, implementation consulting, and integration and support services for digital health projects. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. The company was founded in 2000 and is headquartered in South Yarra, Australia.
|Primary activities||Provider of intelligent informatics software for high performance healthcare|
|Industry / Sector||Health Information Services / Healthcare|
|Mailing address||9 Yarra Street Level 10 South Yarra VIC 3141 Australia|
|Phone / Fax||61 3 8060 6177 /|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Alcidion Group does not pay dividends.
As of May 2021, following are the company executives and directors listed on Alcidion Group.
|Ms. Kate Quirke||MD, CEO & Exec. Director||455.23k|
|Mr. Raymond Howard Blight||Co-Founder & Non-Exec. Director||182.33k|
|Mr. Colin Bruce MacKinnon||CFO & COO||362.5k|
|Prof. Malcolm Pradhan||Chief Medical Officer, Product Mang. & Exec. Director||300.7k|
|Ms. Tracey Harvey||HR Mang.|
|Ms. Melanie Jaye Leydin C.A., B.Bus, CA||Company Sec.||47|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Alcidion Group is 361.6M and its enterprise value is 359.29M. The enterprise value to revenue ratio of ALC is 16.67.
The ALC's stocks Beta value is 0.85 making it 15% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Alcidion Group (ALC)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Alcidion Group (ASX:ALC) Frequently Asked Questions
1. What is Alcidion Group's Stock Symbol?
Alcidion Group trades on ASX under the ticker symbol "ALC".
2. What is Alcidion Group's stock price today?
One share of ALC stock can currently be purchased for approximately $0.365.
3. How can I contact Alcidion Group?
Alcidion Group's mailing address is 9 Yarra Street Level 10 South Yarra VIC 3141 Australia. The company can be reached via phone at 61 3 8060 6177.
4. What is Alcidion Group's official website?
The official website of Alcidion Group is http://www.alcidion.com.
5. Which share registry manages Alcidion Group's stock?
Alcidion Group's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.